Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns two patent technology for Paclitaxel intermediate 10-DAB III production.

A method of Extracting and Purifying 10- Deacetyl Baccatin III Patent Number: ZL 03 1 29635.1 Identify Code: C07D305/14 Issue Date: 18 May, 2005

A Synthetic method of Docetaxel
Patent Publication Number: CN1931849

Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.